AP2757A - Process for preparation of HIV protease inhibitors - Google Patents
Process for preparation of HIV protease inhibitorsInfo
- Publication number
- AP2757A AP2757A AP2008004641A AP2008004641A AP2757A AP 2757 A AP2757 A AP 2757A AP 2008004641 A AP2008004641 A AP 2008004641A AP 2008004641 A AP2008004641 A AP 2008004641A AP 2757 A AP2757 A AP 2757A
- Authority
- AP
- ARIPO
- Prior art keywords
- preparation
- protease inhibitors
- hiv protease
- hiv
- inhibitors
- Prior art date
Links
- 239000004030 hiv protease inhibitor Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C327/00—Thiocarboxylic acids
- C07C327/38—Amides of thiocarboxylic acids
- C07C327/40—Amides of thiocarboxylic acids having carbon atoms of thiocarboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C327/42—Amides of thiocarboxylic acids having carbon atoms of thiocarboxamide groups bound to hydrogen atoms or to acyclic carbon atoms to hydrogen atoms or to carbon atoms of a saturated carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/665—Phosphorus compounds having oxygen as a ring hetero atom, e.g. fosfomycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C253/00—Preparation of carboxylic acid nitriles
- C07C253/30—Preparation of carboxylic acid nitriles by reactions not involving the formation of cyano groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
- C07C303/36—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids
- C07C303/38—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids by reaction of ammonia or amines with sulfonic acids, or with esters, anhydrides, or halides thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
- C07C303/36—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids
- C07C303/40—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids by reactions not involving the formation of sulfonamide groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/22—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms
- C07C311/29—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
- C07C51/41—Preparation of salts of carboxylic acids
- C07C51/412—Preparation of salts of carboxylic acids by conversion of the acids, their salts, esters or anhydrides with the same carboxylic acid part
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/40—Esters thereof
- C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4006—Esters of acyclic acids which can have further substituents on alkyl
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/40—Esters thereof
- C07F9/4071—Esters thereof the ester moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4075—Esters with hydroxyalkyl compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/40—Esters thereof
- C07F9/4071—Esters thereof the ester moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4084—Esters with hydroxyaryl compounds
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Virology (AREA)
- Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Epidemiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US78712606P | 2006-03-29 | 2006-03-29 | |
PCT/US2007/007564 WO2007126812A2 (en) | 2006-03-29 | 2007-03-29 | Process for preparation of hiv protease inhibitors |
Publications (2)
Publication Number | Publication Date |
---|---|
AP2008004641A0 AP2008004641A0 (en) | 2008-10-31 |
AP2757A true AP2757A (en) | 2013-09-30 |
Family
ID=38323963
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AP2008004641A AP2757A (en) | 2006-03-29 | 2007-03-29 | Process for preparation of HIV protease inhibitors |
AP2013006690A AP2013006690A0 (en) | 2006-03-29 | 2007-03-29 | Process for preparation of HIV protease inhibitors |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AP2013006690A AP2013006690A0 (en) | 2006-03-29 | 2007-03-29 | Process for preparation of HIV protease inhibitors |
Country Status (25)
Country | Link |
---|---|
US (4) | US20110065631A1 (ru) |
EP (2) | EP1999133B1 (ru) |
JP (2) | JP5430395B2 (ru) |
KR (2) | KR101429300B1 (ru) |
CN (2) | CN101448838B (ru) |
AP (2) | AP2757A (ru) |
AU (1) | AU2007245194B2 (ru) |
BR (1) | BRPI0710199A2 (ru) |
CA (1) | CA2647316C (ru) |
DK (1) | DK1999133T3 (ru) |
EA (2) | EA016140B1 (ru) |
ES (2) | ES2430557T3 (ru) |
HK (2) | HK1180311A1 (ru) |
HR (2) | HRP20080554B1 (ru) |
IL (2) | IL194122A (ru) |
MX (1) | MX2008012398A (ru) |
NO (2) | NO342102B1 (ru) |
NZ (2) | NZ596074A (ru) |
PL (1) | PL1999133T3 (ru) |
PT (1) | PT1999133E (ru) |
SG (1) | SG170794A1 (ru) |
SI (1) | SI1999133T1 (ru) |
UA (1) | UA97241C2 (ru) |
WO (1) | WO2007126812A2 (ru) |
ZA (1) | ZA200808046B (ru) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8921415B2 (en) | 2009-01-29 | 2014-12-30 | Mapi Pharma Ltd. | Polymorphs of darunavir |
US8829208B2 (en) | 2010-01-28 | 2014-09-09 | Mapi Pharma Ltd. | Process for the preparation of darunavir and darunavir intermediates |
CN102190638A (zh) * | 2010-03-16 | 2011-09-21 | 中国科学院上海药物研究所 | 联芳基醇二胺类化合物、其药物组合物、制备方法及应用 |
CN102584748B (zh) * | 2011-01-13 | 2015-02-11 | 浙江九洲药业股份有限公司 | 夫沙那韦中间体的制备方法 |
PT2702045T (pt) * | 2011-04-26 | 2018-01-11 | Mylan Laboratories Ltd | Método inovador para a preparação de etravirina |
MX353064B (es) * | 2011-10-07 | 2017-12-19 | Gilead Sciences Inc | Metodos para preparar analogos nucleotidicos antivirales. |
EP2634180A1 (en) | 2012-03-01 | 2013-09-04 | Lonza Ltd. | Enzymatic process for the preparation of butyrolactones |
CN103664976B (zh) * | 2013-12-12 | 2015-11-04 | 惠州市莱佛士制药技术有限公司 | 一种顺式六氢呋喃并[2,3-b]呋喃-3-醇的制备方法 |
WO2015123282A1 (en) * | 2014-02-12 | 2015-08-20 | Fotsing Joseph R | Improved process for the synthesis of substituted 1-benzyl-3-(1-(isoxazol-4-ylmethyl)-1h-pyrazol-4-yl)imidazolidine-2,4-diones |
RS62434B1 (sr) | 2014-12-26 | 2021-11-30 | Univ Emory | Antivirusni n4-hidroksicitidin derivati |
JP6435907B2 (ja) * | 2015-02-16 | 2018-12-12 | 住友化学株式会社 | ヘキサヒドロフロフラノール誘導体の製造方法 |
CN108610227B (zh) * | 2016-12-10 | 2021-02-09 | 中国科学院大连化学物理研究所 | 一种制备双环芳香化合物的方法 |
KR102626210B1 (ko) | 2017-12-07 | 2024-01-18 | 에모리 유니버시티 | N4-하이드록시사이티딘 및 유도체 및 이와 관련된 항-바이러스 용도 |
CA3125991A1 (en) | 2019-01-25 | 2020-07-30 | Brown University | Compositions and methods for treating, preventing or reversing age-associated inflammation and disorders |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994026749A1 (en) * | 1993-05-14 | 1994-11-24 | Merck & Co., Inc. | Hiv protease inhibitors |
WO2002067239A2 (en) * | 2000-10-24 | 2002-08-29 | Glaxo Group Limited | Process for preparing intermediates of hiv protease inhibitors |
WO2005042772A1 (en) * | 2003-10-24 | 2005-05-12 | Gilead Sciences, Inc. | Methods and compositions for identifying therapeutic compounds |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU1369001A (en) * | 1995-12-13 | 2001-03-22 | Abbott Laboratories | Retroviral protease inhibiting compounds |
EP1244610B1 (en) | 1999-12-23 | 2008-07-16 | Ampac Fine Chemicals LLC | Improved preparation of 2s,3s-n-isobutyl-n-(2-hydroxy-3-amino-4-phenylbutyl)-p-nitrobenzenesulfonylamide hydrochloride and other derivatives of 2-hydroxy-1,3-diamines |
EP1436884A2 (en) | 2001-07-20 | 2004-07-14 | Koninklijke Philips Electronics N.V. | Oscillating circuit, converter with such oscillating circuit, and preconditioner with such converter |
US20050239054A1 (en) * | 2002-04-26 | 2005-10-27 | Arimilli Murty N | Method and compositions for identifying anti-HIV therapeutic compounds |
CN1656109A (zh) * | 2002-04-26 | 2005-08-17 | 吉里德科学公司 | 非核苷逆转录酶抑制剂 |
-
2007
- 2007-03-29 EA EA200802074A patent/EA016140B1/ru not_active IP Right Cessation
- 2007-03-29 PL PL07754134T patent/PL1999133T3/pl unknown
- 2007-03-29 KR KR1020087026569A patent/KR101429300B1/ko active IP Right Grant
- 2007-03-29 CN CN2007800178888A patent/CN101448838B/zh active Active
- 2007-03-29 AP AP2008004641A patent/AP2757A/xx active
- 2007-03-29 MX MX2008012398A patent/MX2008012398A/es active IP Right Grant
- 2007-03-29 UA UAA200811574A patent/UA97241C2/ru unknown
- 2007-03-29 EP EP07754134.0A patent/EP1999133B1/en active Active
- 2007-03-29 AU AU2007245194A patent/AU2007245194B2/en active Active
- 2007-03-29 DK DK07754134.0T patent/DK1999133T3/da active
- 2007-03-29 US US12/293,450 patent/US20110065631A1/en not_active Abandoned
- 2007-03-29 CA CA2647316A patent/CA2647316C/en active Active
- 2007-03-29 EP EP12192910.3A patent/EP2570416B1/en active Active
- 2007-03-29 EA EA201100994A patent/EA020088B1/ru not_active IP Right Cessation
- 2007-03-29 SI SI200731323T patent/SI1999133T1/sl unknown
- 2007-03-29 KR KR1020137034899A patent/KR101395377B1/ko active IP Right Grant
- 2007-03-29 AP AP2013006690A patent/AP2013006690A0/xx unknown
- 2007-03-29 SG SG201102217-5A patent/SG170794A1/en unknown
- 2007-03-29 BR BRPI0710199-6A patent/BRPI0710199A2/pt not_active IP Right Cessation
- 2007-03-29 ES ES07754134T patent/ES2430557T3/es active Active
- 2007-03-29 WO PCT/US2007/007564 patent/WO2007126812A2/en active Application Filing
- 2007-03-29 PT PT77541340T patent/PT1999133E/pt unknown
- 2007-03-29 US US11/729,522 patent/US8173623B2/en active Active
- 2007-03-29 ES ES12192910T patent/ES2572001T3/es active Active
- 2007-03-29 JP JP2009502946A patent/JP5430395B2/ja active Active
- 2007-03-29 NZ NZ596074A patent/NZ596074A/xx not_active IP Right Cessation
- 2007-03-29 NZ NZ571302A patent/NZ571302A/en not_active IP Right Cessation
- 2007-03-29 CN CN201110315578.2A patent/CN102516259B/zh active Active
-
2008
- 2008-09-16 IL IL194122A patent/IL194122A/en not_active IP Right Cessation
- 2008-09-19 ZA ZA200808046A patent/ZA200808046B/xx unknown
- 2008-10-28 NO NO20084547A patent/NO342102B1/no unknown
- 2008-10-29 HR HRP20080554AA patent/HRP20080554B1/hr not_active IP Right Cessation
-
2009
- 2009-06-10 HK HK13107502.1A patent/HK1180311A1/zh unknown
- 2009-06-10 HK HK09105198.0A patent/HK1126756A1/xx unknown
-
2012
- 2012-02-21 US US13/401,659 patent/US8431745B2/en active Active
- 2012-12-12 JP JP2012271186A patent/JP2013082717A/ja not_active Withdrawn
-
2013
- 2013-02-27 US US13/779,188 patent/US20130172295A1/en not_active Abandoned
- 2013-03-12 IL IL225167A patent/IL225167A/en not_active IP Right Cessation
-
2014
- 2014-07-01 HR HRP20140626AA patent/HRP20140626A2/hr not_active Application Discontinuation
-
2018
- 2018-01-17 NO NO20180086A patent/NO342965B1/no unknown
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994026749A1 (en) * | 1993-05-14 | 1994-11-24 | Merck & Co., Inc. | Hiv protease inhibitors |
WO2002067239A2 (en) * | 2000-10-24 | 2002-08-29 | Glaxo Group Limited | Process for preparing intermediates of hiv protease inhibitors |
WO2005042772A1 (en) * | 2003-10-24 | 2005-05-12 | Gilead Sciences, Inc. | Methods and compositions for identifying therapeutic compounds |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AP2757A (en) | Process for preparation of HIV protease inhibitors | |
HK1223370A1 (zh) | 製備整合酶抑制劑的方法和中間體 | |
EP2224920A4 (en) | PROCESS FOR THE PREPARATION OF MACROCYCLIC OXIMYL HEPATITIS C PROTEASE INHIBITORS | |
EP2051707A4 (en) | Plasma kallikrein INHIBITORS | |
HK1166308A1 (zh) | 激活酶抑制劑 | |
HK1132754A1 (en) | 4-amino-4-oxobutanoyl peptides as inhibitors of viral replication | |
IL200611A0 (en) | Inhibitors of serine proteases | |
ZA200900551B (en) | Process for the preparation of 2-substituted-5-(1-alkylthio)alkylpyridines | |
EP2139883A4 (en) | INHIBITORS OF HIV-1 PROTEASE | |
EP2099789A4 (en) | INHIBITORS OF HIV REPLICATION | |
HK1127345A1 (en) | Azapeptide derivatives as hiv protease inhibitors | |
EP2304043A4 (en) | HIV PROTEASE INHIBITORS AND METHOD FOR THEIR USE | |
EP2088136A4 (en) | PROCESS FOR PRODUCING HYDROXYADAMANTANE-AMINE | |
EP2244571A4 (en) | SMALL INHIBITORY MOLECULES OF HIV PROTEASES | |
EP2134336A4 (en) | HIV PROTEASE INHIBITORS DERIVED FROM BENZOFURAN | |
EP2096103A4 (en) | PROCESS FOR THE PRODUCTION OF BETAINE | |
EP2057151A4 (en) | PROCESS FOR PURIFYING APREPITANT | |
EP2291077A4 (en) | METHOD OF MANUFACTURING RHO-KINASE INHIBITOR COMPOUNDS | |
EP2144871A4 (en) | AMIDATION METHOD FOR THE PREPARATION OF CATHEPSIN K INHIBITORS | |
GB0621669D0 (en) | Process for preparation of l-gluconic acid | |
ZA201201740B (en) | Process for the preparation of cathepsin s inhibitors | |
EP1984525A4 (en) | METHODS FOR DETERMINING HIV RESISTANCE TO TREATMENTS WITH PROTEASE INHIBITOR | |
EP1985611A4 (en) | PROCESS FOR THE PREPARATION OF O-METHYL-N-NITROISOHARNSTOFF | |
IL198836A0 (en) | Processes for preparation of 9-haloacetamidomidominocyclines | |
IL193470A0 (en) | Process for preparing of 2-alkyl-3-aryl-prop-2- ene-1-ols |